Seeing Is Believing
BDTX is currently covered by 3 analysts with an average potential upside of $5.06 (50.52%) backed by displayed 0 price targets and 7 ratings.
Analysts average stock forecasts to be materialized ratio is 77.78% with an average time for these price targets to be met of 95 days.
Highest price target for BDTX is 6, Lowest price target is 1, average price target is 3.5.
Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 12-Sep-2023. First documented stock forecast 24-Feb-2020.
Currently, out of the existing stock ratings of BDTX - 5 which are a Hold (71.43%), 2 which are a Buy (28.57%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
3
2 months 17 days ago
2/2 (100%)
$1.16 (50.96%)
94
Hold
2
$-0.23 (-10.31%)
4
8 months 19 days ago
2/2 (100%)
$0.74 (37.17%)
117
Buy
24
$22.42 (1418.99%)
44
2 years 6 months 9 days ago
1/3 (33.33%)
$13.28 (63.42%)
74
What is BDTX (Black Diamond Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BDTX (Black Diamond Therapeutics) with a proven track record?
Which analyst has the current lower performing score on BDTX (Black Diamond Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BDTX (Black Diamond Therapeutics)?
Which analyst is the currently most bullish on BDTX (Black Diamond Therapeutics)?
Which analyst is the currently most reserved on BDTX (Black Diamond Therapeutics)?